Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,692 | -16,740 |
| Depreciation Amortization | 1,601 | 1,467 |
| Other Working Capital | -2,526 | 3,469 |
| Other Operating Activity | -843 | 3,233 |
| Operating Cash Flow | $-6,460 | $-8,571 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -52 | -53 |
| Investing Cash Flow | $-52 | $-53 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 10,557 | 8,222 |
| Financing Cash Flow | $10,557 | $8,222 |
| Beginning Cash Position | 251 | 653 |
| End Cash Position | 4,296 | 251 |
| Net Cash Flow | $4,045 | $-402 |
| Free Cash Flow | ||
| Operating Cash Flow | -6,460 | -8,571 |
| Capital Expenditure | -52 | N/A |
| Free Cash Flow | -6,512 | -8,571 |